Suita, Japan

Shota Nakamura



Average Co-Inventor Count = 9.1

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shota Nakamura

Introduction

Shota Nakamura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medical technology, particularly in the detection of conjunctival diseases and aging biomarkers. With a total of two patents to his name, his work is paving the way for advancements in ocular health.

Latest Patents

Nakamura's latest patents include a method for detecting conjunctival disease using ocular surface tissue. This innovative method involves comparing the microbial community structure of a microbiota in ocular surface tissue specimens from healthy individuals with those from subjects showing signs of conjunctival diseases. His second patent focuses on an aging biomarker that serves as an indicator of the aging state of a subject. This biomarker comprises bacterial species from the Corynebacteriaceae family or the Propionibacteriales family found in ocular surface tissue.

Career Highlights

Throughout his career, Shota Nakamura has worked with esteemed institutions such as Osaka University and Bikenbiomics Co., Ltd. His research has contributed to a deeper understanding of ocular health and the implications of microbial communities in disease detection.

Collaborations

Nakamura has collaborated with notable colleagues, including Daisuke Motooka and Tetsuya Iida. Their combined expertise has further enhanced the impact of his research in the medical field.

Conclusion

Shota Nakamura's innovative work in the detection of conjunctival diseases and aging biomarkers showcases his commitment to advancing medical technology. His contributions are significant in improving health outcomes and understanding ocular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…